File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Development and clinical trial of a novel bioactive bone cement

TitleDevelopment and clinical trial of a novel bioactive bone cement
Authors
KeywordsBioactive bone cement
Osteoporosis
Strontium
Total hip replacement
Vertebroplasty
Issue Date2008
PublisherGaodeng Jiaoyu Chubanshe. The Journal's web site is located at http://www.springer.com/medicine/journal/11684
Citation
Frontiers Of Medicine In China, 2008, v. 2 n. 2, p. 117-126 How to Cite?
AbstractStrontium (Sr) and related compounds have become more attractive in the prevention and treatment of osteoporosis. Previously, we developed a novel bioactive bone cement which is mainly composed of strontium-containing hydroxyapatite (Sr-HA) filler and bisphenol A diglycidylether dimethacrylate (Bis-GMA) resin. This bone cement is superior to conventional polymethylmethacrylate (PMMA) bone cement in bioactivity, biocompatibility, and osseointegration. It also has shown sufficient mechanical strength properties for its use in percutaneous vertebroplasty (PVP) and total hip replacement (THR). In this paper, we review the in vitro, in vivo and clinical evidence for the effectiveness of this bioactive bone cement. © Higher Education Press and Springer-Verlag GmbH 2008.
Persistent Identifierhttp://hdl.handle.net/10722/79588
ISSN
References

 

DC FieldValueLanguage
dc.contributor.authorLeong, JCen_HK
dc.contributor.authorLi, Zen_HK
dc.contributor.authorLu, WWen_HK
dc.date.accessioned2010-09-06T07:56:21Z-
dc.date.available2010-09-06T07:56:21Z-
dc.date.issued2008en_HK
dc.identifier.citationFrontiers Of Medicine In China, 2008, v. 2 n. 2, p. 117-126en_HK
dc.identifier.issn1673-7342en_HK
dc.identifier.urihttp://hdl.handle.net/10722/79588-
dc.description.abstractStrontium (Sr) and related compounds have become more attractive in the prevention and treatment of osteoporosis. Previously, we developed a novel bioactive bone cement which is mainly composed of strontium-containing hydroxyapatite (Sr-HA) filler and bisphenol A diglycidylether dimethacrylate (Bis-GMA) resin. This bone cement is superior to conventional polymethylmethacrylate (PMMA) bone cement in bioactivity, biocompatibility, and osseointegration. It also has shown sufficient mechanical strength properties for its use in percutaneous vertebroplasty (PVP) and total hip replacement (THR). In this paper, we review the in vitro, in vivo and clinical evidence for the effectiveness of this bioactive bone cement. © Higher Education Press and Springer-Verlag GmbH 2008.en_HK
dc.languageengen_HK
dc.publisherGaodeng Jiaoyu Chubanshe. The Journal's web site is located at http://www.springer.com/medicine/journal/11684en_HK
dc.relation.ispartofFrontiers of Medicine in Chinaen_HK
dc.subjectBioactive bone cementen_HK
dc.subjectOsteoporosisen_HK
dc.subjectStrontiumen_HK
dc.subjectTotal hip replacementen_HK
dc.subjectVertebroplastyen_HK
dc.titleDevelopment and clinical trial of a novel bioactive bone cementen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1673-7342&volume=2&issue=2&spage=117&epage=26&date=2008&atitle=Development+and+clinical+trial+of+a+novel+bioactive+bone+cementen_HK
dc.identifier.emailLu, WW:wwlu@hku.hken_HK
dc.identifier.authorityLu, WW=rp00411en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s11684-008-0022-1en_HK
dc.identifier.scopuseid_2-s2.0-44649146412en_HK
dc.identifier.hkuros144032en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-44649146412&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume2en_HK
dc.identifier.issue2en_HK
dc.identifier.spage117en_HK
dc.identifier.epage126en_HK
dc.publisher.placeChinaen_HK
dc.identifier.scopusauthoridLeong, JC=35563743000en_HK
dc.identifier.scopusauthoridLi, Z=35784563200en_HK
dc.identifier.scopusauthoridLu, WW=7404215221en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats